Gene: CREBBP
Official Full Name: CREB binding proteinprovided by HGNC
Gene Summary: This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00571 | CREBBP knockout cell line (HCT 116) | Human | CREBBP | 1:2~1:4 | Negative | Online Inquiry |
KO11315 | CREBBP Knockout cell line (HeLa) | Human | CREBBP | 1:3~1:6 | Negative | Online Inquiry |
KO11316 | CREBBP Knockout cell line (HEK293) | Human | CREBBP | 1:3~1:6 | Negative | Online Inquiry |
KO11317 | CREBBP Knockout cell line (A549) | Human | CREBBP | 1:3~1:4 | Negative | Online Inquiry |
CREBBP Gene Knockout Cell Lines represent a valuable tool in the field of molecular biology and genetics, designed to facilitate the exploration of the CREBBP gene, which encodes a critical transcriptional coactivator involved in a variety of cellular processes, including differentiation, development, and response to external signals. By creating specific knockouts of the CREBBP gene in cellular models, researchers can effectively delineate the functional roles of this gene in various biological contexts.
These cell lines operate through the targeted deletion of the CREBBP gene using advanced genome-editing technologies such as CRISPR-Cas9. This technique allows for precise modifications at specific genomic loci, resulting in knockout cells that provide a unique opportunity to study the resulting phenotypic changes. The removal of CREBBP offers insights into its role in oncogenesis and other pathologies linked to aberrant signaling pathways, disease progression, and metabolic regulation.
The scientific importance of CREBBP Gene Knockout Cell Lines is underscored by their applications in research tackling various medical conditions, such as cancers influenced by dysregulated transcriptional control and metabolic disorders linked to gene expression abnormalities. Additionally, these cell lines can be instrumental in drug discovery and therapeutic development by facilitating in vitro screening of compounds that may correct or modulate the effects of CREBBP loss.
One of the key advantages of our CREBBP Gene Knockout Cell Lines is their high specificity and replicability, which enhances the reliability of experimental outcomes when compared to alternative methods like siRNA knockdown or pharmacological inhibition. Our product comes optimized for diverse applications across various assay formats, ensuring compatibility with existing research protocols.
For researchers and clinicians, the value of these cell lines lies in their ability to provide a robust model for studying gene functions and pathways implicated in disease. This can pave the way for novel therapeutic strategies and deepen our understanding of complex biological systems.
With our company’s extensive expertise in developing high-quality biological models, we are committed to advancing research and enriching the scientific community’s resources, making our CREBBP Gene Knockout Cell Lines a vital addition to any laboratory focused on genetics and its applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.